X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
index medicus (38) 38
female (30) 30
adult (28) 28
male (27) 27
diabetes (26) 26
endocrinology & metabolism (24) 24
middle aged (22) 22
diabetes mellitus (19) 19
type 2 diabetes (17) 17
mellitus (16) 16
risk factors (14) 14
aged (13) 13
turkey (12) 12
prevalence (11) 11
adolescent (10) 10
obesity (10) 10
diabetes mellitus, type 2 - drug therapy (9) 9
glucose (9) 9
hypoglycemic agents - therapeutic use (9) 9
body mass index (8) 8
mortality (8) 8
research (8) 8
treatment outcome (8) 8
turkey - epidemiology (8) 8
glycated hemoglobin a - analysis (7) 7
glycemic control (7) 7
risk (7) 7
blood pressure (6) 6
blood-pressure (6) 6
cardiovascular disease (6) 6
child (6) 6
diabetes mellitus, type 2 - blood (6) 6
epidemiology (6) 6
gliclazide (6) 6
health aspects (6) 6
metabolic syndrome (6) 6
population (6) 6
prevention (6) 6
research article (6) 6
type 1 diabetes (6) 6
type 2 diabetes mellitus (6) 6
association (5) 5
blood glucose - metabolism (5) 5
dextrose (5) 5
diabetes mellitus, type 2 - complications (5) 5
diabetics (5) 5
fasting (5) 5
hypoglycemia (5) 5
medicine, general & internal (5) 5
quality of life (5) 5
time factors (5) 5
young adult (5) 5
adults (4) 4
article (4) 4
blood glucose - analysis (4) 4
blood glucose - drug effects (4) 4
children (4) 4
complications (4) 4
coronary-heart-disease (4) 4
diabetes mellitus, type 1 - blood (4) 4
diabetes mellitus, type 1 - drug therapy (4) 4
disease (4) 4
drug therapy (4) 4
endocrinology (4) 4
genetics & heredity (4) 4
glucose tolerance tests (4) 4
glycosylated hemoglobin (4) 4
health (4) 4
health risk assessment (4) 4
hypoglycemic agents (4) 4
insulin - therapeutic use (4) 4
interventions (4) 4
management (4) 4
medicine, research & experimental (4) 4
outcomes (4) 4
risk-factors (4) 4
studies (4) 4
treatment (4) 4
adherence (3) 3
age factors (3) 3
cardiovascular disease mortality (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - mortality (3) 3
care and treatment (3) 3
cholesterol (3) 3
clinical medicine (3) 3
cross-sectional studies (3) 3
diabetes mellitus - blood (3) 3
diabetes mellitus, type 2 - epidemiology (3) 3
diabetes mellitus, type 2 - physiopathology (3) 3
dosage and administration (3) 3
double-blind method (3) 3
drug administration schedule (3) 3
enzymes (3) 3
europe (3) 3
follow-up studies (3) 3
gastroenterology and hepatology (3) 3
gender (3) 3
genes (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Epidemiology, ISSN 0393-2990, 1/2013, Volume 28, Issue 2, pp. 169 - 180
Journal Article
Journal Article
DIABETOLOGY & METABOLIC SYNDROME, ISSN 1758-5996, 04/2018, Volume 10, Issue 1, pp. 30 - 30
Background: Although the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide) remain an important option... 
Type 2 diabetes | Glycemic control | MORTALITY | MODIFIED-RELEASE GLICLAZIDE | SULFONYLUREA | CARDIOVASCULAR OUTCOMES | SAXAGLIPTIN | Real-world | SITAGLIPTIN | RANDOMIZED-TRIAL | Tolerability | RAMADAN | ENDOCRINOLOGY & METABOLISM | Gliclazide | HYPOGLYCEMIA | EMPAGLIFLOZIN | Body mass index | Dosage and administration | Drug therapy | Health aspects
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2019, Volume 14, Issue 3, pp. e0214122 - e0214122
Journal Article
Sexuality and Disability, ISSN 0146-1044, 6/2015, Volume 33, Issue 2, pp. 233 - 241
Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article